Literature DB >> 21913218

Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles.

Emmanuel Gibon1, Ting Ma, Pei-Gen Ren, Kate Fritton, Sandip Biswal, Zhenyu Yao, Lane Smith, Stuart B Goodman.   

Abstract

The biological mechanisms leading to periprosthetic osteolysis involve both chemokines and the monocyte/macrophage cell lineage. Whether MCP-1 plays a major role in macrophage recruitment in the presence of wear particles is unknown. We tested two hypotheses: (1) that exogenous local delivery of MCP-1 induces systematic macrophage recruitment and (2) that blockade of the MCP-1 ligand-receptor axis decreases macrophage recruitment and osteolysis in the presence of ultra high molecular weight polyethylene (UHMWPE) particles. Six groups of nude mice were used. We used non-invasive imaging to assay macrophage recruitment and osteolysis. A murine macrophage cell line and primary wild type and CCR2 knockout murine macrophages were used as the reporter cells. Particles were infused into the femoral canal. Bioluminescence and immunohistochemical staining were used to confirm the migration of reporter cells. Locally infused MCP-1 induced systemic macrophage trafficking to bone. Injection of MCP-1 receptor antagonist significantly decreased reporter cell recruitment to bone infused with UHMWPE particles and decreased osteolysis. Systemic migration of reporter cells to infused particles was decreased when the reporter cells were deficient in the CCR2 receptor. Interruption of the MCP-1 ligand-receptor axis appears to be a viable strategy to mitigate trafficking of macrophages and osteolysis due to UHMWPE particles.
Copyright © 2011 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913218      PMCID: PMC3241865          DOI: 10.1002/jor.21548

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  47 in total

1.  Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis.

Authors:  Pei-Gen Ren; Afraaz Irani; Zhinong Huang; Ting Ma; Sandip Biswal; Stuart B Goodman
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

2.  Surveillance of systemic trafficking of macrophages induced by UHMWPE particles in nude mice by noninvasive imaging.

Authors:  Pei-Gen Ren; Zhinong Huang; Ting Ma; Sandip Biswal; Robert L Smith; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2010-09-01       Impact factor: 4.396

3.  Cellular chemotaxis induced by wear particles from joint replacements.

Authors:  Stuart B Goodman; Ting Ma
Journal:  Biomaterials       Date:  2010-04-15       Impact factor: 12.479

4.  Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro.

Authors:  B Yaszay; M C Trindade; M Lind; S B Goodman; R L Smith
Journal:  J Orthop Res       Date:  2001-09       Impact factor: 3.494

5.  Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles.

Authors:  T R Green; J Fisher; J B Matthews; M H Stone; E Ingham
Journal:  J Biomed Mater Res       Date:  2000-09

6.  G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 release in vitro.

Authors:  M C Trindade; D J Schurman; W J Maloney; S B Goodman; R L Smith
Journal:  J Biomed Mater Res       Date:  2000-09-05

7.  Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells.

Authors:  Zhinong Huang; Ting Ma; Pei-Gen Ren; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2010-09-15       Impact factor: 4.396

8.  The epidemiology of bearing surface usage in total hip arthroplasty in the United States.

Authors:  Kevin J Bozic; Steven Kurtz; Edmund Lau; Kevin Ong; Vanessa Chiu; Thomas P Vail; Harry E Rubash; Daniel J Berry
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

9.  Continuous intramedullary polymer particle infusion using a murine femoral explant model.

Authors:  Steven G Ortiz; Ting Ma; Donald Regula; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-11       Impact factor: 3.368

10.  Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.

Authors:  Nikolaus B Binder; Birgit Niederreiter; Oskar Hoffmann; Richard Stange; Thomas Pap; Thomas M Stulnig; Matthias Mack; Reinhold G Erben; Josef S Smolen; Kurt Redlich
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

View more
  43 in total

1.  Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles.

Authors:  Zhenyu Yao; Michael Keeney; Tzu-Hua Lin; Jukka Pajarinen; Katherine Barcay; Heather Waters; Kensuke Egashira; Fan Yang; Stuart Goodman
Journal:  J Biomed Mater Res A       Date:  2013-11-20       Impact factor: 4.396

2.  Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particles.

Authors:  Kate Fritton; Pei-Gen Ren; Emmanuel Gibon; Allison J Rao; Ting Ma; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2012-08-14       Impact factor: 3.845

3.  Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo.

Authors:  Xinyi Jiang; Taishi Sato; Zhenyu Yao; Michael Keeney; Jukka Pajarinen; Tzu-Hua Lin; Florence Loi; Kensuke Egashira; Stuart Goodman; Fan Yang
Journal:  J Orthop Res       Date:  2015-07-29       Impact factor: 3.494

4.  Role of macrophages in the biological reaction to wear debris from joint replacements.

Authors:  Christophe Nich; Stuart B Goodman
Journal:  J Long Term Eff Med Implants       Date:  2014

5.  Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss.

Authors:  Emmanuel Gibon; Zhenyu Yao; Allison J Rao; Stefan Zwingenberger; Barbara Batke; Roberto Valladares; Robert L Smith; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Biomaterials       Date:  2012-02-23       Impact factor: 12.479

Review 6.  Macrophages-Key cells in the response to wear debris from joint replacements.

Authors:  Christophe Nich; Yuya Takakubo; Jukka Pajarinen; Mari Ainola; Abdelhakim Salem; Tarvo Sillat; Allison J Rao; Milan Raska; Yasunobu Tamaki; Michiaki Takagi; Yrjö T Konttinen; Stuart B Goodman; Jiri Gallo
Journal:  J Biomed Mater Res A       Date:  2013-04-09       Impact factor: 4.396

Review 7.  Immunobiology of periprosthetic inflammation and pain following ultra-high-molecular-weight-polyethylene wear debris in the lumbar spine.

Authors:  John H Werner; John H Rosenberg; Kristen L Keeley; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2018-08-21       Impact factor: 4.473

8.  Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.

Authors:  Alexandru Movila; Takenobu Ishii; Abdullah Albassam; Wichaya Wisitrasameewong; Mohammed Howait; Tsuguno Yamaguchi; Montserrat Ruiz-Torruella; Laila Bahammam; Kazuaki Nishimura; Thomas Van Dyke; Toshihisa Kawai
Journal:  J Bone Miner Res       Date:  2016-06-02       Impact factor: 6.741

9.  Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.

Authors:  Allison J Rao; Christophe Nich; Lakshmi S Dhulipala; Emmanuel Gibon; Roberto Valladares; Stefan Zwingenberger; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2012-12-05       Impact factor: 4.396

10.  Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity.

Authors:  Leah A Mitchell; Ryan J Hansen; Adam J Beaupre; Daniel L Gustafson; Steven W Dow
Journal:  Int Immunopharmacol       Date:  2012-12-13       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.